-
October 17, 2022 Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks DropMath over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and...
-
November 5, 2021 Psychedelic Business Spotlight: November 5This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher...
-
August 18, 2021 Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast CancerThe company is also pursuing psilocybin as a possible treatment for rare cancers, but they...
